Status:
UNKNOWN
Strengthening in Sub-acute Stroke Survivors: A Randomized Controlled Trial
Lead Sponsor:
Clinique Du Parc de Belleville
Collaborating Sponsors:
Henri Mondor University Hospital
Conditions:
Hemiparesis;Poststroke/CVA
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The goal of this study is to compare between Eccentric training and conventional therapy in sub-acute stroke survivors. The primary objective of this study is to evaluate improvements in gait speed af...
Detailed Description
This study will be a single-blinded, controlled, randomized design, wherein participants will be randomly assigned to one of two groups: the Conventional Therapy Group (CTG) or the Eccentric Training ...
Eligibility Criteria
Inclusion
- Subacute hemiparesis (\> 3 months)
- BMI between 18.5 and 25
- Written consent to participate in the study.
Exclusion
- Ankle impairment
- Botulinum toxin injections in PF within the last 4 months before study inclusion
- Medical contraindication for maximal effort
- Neurodegenerative disorders
- Cardiovascular disorders
- History of epilepsy.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06140381
Start Date
December 1 2023
End Date
October 1 2024
Last Update
November 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wael Maktouf
Créteil, France, 94000